Tag: CBT > DEA Cannabis Policy and Legalization: Page 2

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Cannabis Advertising

The Complex Impact of Rescheduling Cannabis on Advertising

The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.

September 17, 2024

Industry Headlines

MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research

The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.

September 11, 2024

2018 Farm Bill Status

4th Circuit Court Rules THC-O Meets Legal Definition of Hemp, Deviating From DEA

The federal court’s interpretation of the 2018 Farm Bill contradicts the Drug Enforcement Administration’s position that THC-O is illegal.

September 9, 2024

Texas

Allen Police Department, DEA Raid 9 Texas Vape Shops, Destroy Hemp Products

Local authorities accused the shops of selling noncompliant products, sometimes to minors. An attorney said the police and DEA ‘overstepped their authority.’

August 28, 2024

Cannabis Rescheduling

Cannabis Rescheduling No Longer on Fast Track; Hearing Scheduled For December

The DEA will not issue a final rule before the November election now that Administrator Anne Milgram granted an administrative law judge hearing.

August 27, 2024

Cannabis Rescheduling

Cannabis Rescheduling Nearly ‘Done Deal,’ Story Cannabis CEO Says

Jason Vedadi, the former executive chairman for Harvest Health before its acquisition by Trulieve, talks exclusively with CBT on what he expects from federal rescheduling as the industry awaits the DEA’s final determination.

July 29, 2024

Cannabis Rescheduling

43,000 Comments Filed on Cannabis Rescheduling Proposal as Public Period Closes

The Drug Enforcement Administration will now weigh these comments and potentially hold administrative law hearings before issuing a final rule.

July 23, 2024

Kentucky

Kentucky Governor Urges DEA to Reschedule: ‘The Jury is No Longer Out on Marijuana’

Gov. Andy Beshear wrote a letter to DEA Administrator Anne Milgram expressing his support for reclassifying cannabis to a Schedule III substance.

July 17, 2024

Cannabis Rescheduling

US Congressmen Press DEA Head to Explain Her Signature Absence on Cannabis Rescheduling Document

The agency’s administrator, Anne Milgram, did not personally approve the notice of proposed rulemaking to reclassify cannabis on May 16.

May 23, 2024

Banking Services Cannabis Industry

Federal Marijuana Rescheduling on the Horizon: A Big Step Forward But Not the Be-All-End-All

Rescheduling does not make cannabis legal throughout America and the U.S. territories; It makes cannabis a federally regulated medication—and many questions remain about the fate of the industry.

May 23, 2024

Oklahoma

DEA 2024 Report Focuses on THC Potency, Organized Crime, Youth Edible Consumption

The federal agency’s National Drug Threat Assessment calls attention to how scheduled substances and trafficking trends are “endangering” the U.S.

May 17, 2024